Table 2.
Name | Structure | Targets* | Kd (μM) | References |
---|---|---|---|---|
Lactose | Gal-1 | 330 | (12) | |
Gal-2 | 85 | (13) | ||
Gal-3 | 26-1000 | (13) | ||
Gal-8 | 150 | (14) | ||
Gal-9 | N.A. | (15) | ||
Gal-12 | N.A. | (16) | ||
TDG | Gal-1 | 24 | (17) | |
Gal-2 | 340 | |||
Gal-3 | 49 | |||
Gal-8 | 61 | |||
Gal-9 | 38 | |||
TD 139 | Gal-1 | 0.012 | (17) | |
Gal-2 | >5 | |||
Gal-3 | 0.014 | |||
Gal-8 | 86 | |||
Gal-9 | 0.68 | |||
GB 1107 | Gal-1 | 3.7 | (18) | |
Gal-2 | 0.64 | |||
Gal-3 | 0.037 | |||
Gal-8 | 83 | |||
Gal-9 | 2.4 | |||
G3-C12 | Ala-Asn-Thr-Pro-Cys-Gly-Pro-Tyr- | Gal-3 | 0.088 | (19) |
Thr-His-Asp-Cys-Pro-Val-Lys-Arg |
Targets involved galectins expressed by immune cells.
N.A., not available.